Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Tricia Elliott MD, FAAFP
Tricia C. Elliott MD, FAAFP Associate Editor
Robert Bonakdar MD, FAAFP, FACN
Robert Bonakdar MD, FAAFP, FACN Advisory Board
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
See All Experts
story of the week
Published in Primary Care and
1 other channel

Journal Scan / Research · April 25, 2016

Anticholinergic Use and Cognition and Brain Atrophy in Cognitively Normal Older Adults

JAMA Neurology

 

 Save  Recommend
 Share

Additional Info

JAMA Neurology
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults
JAMA Neurol 2016 Apr 18;[EPub Ahead of Print], SL Risacher, BC McDonald, EF Tallman, JD West, MR Farlow, FW Unverzagt, S Gao, M Boustani, PK Crane, RC Petersen, CR Jack, WJ Jagust, PS Aisen, MW Weiner, AJ Saykin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated